FDA backs new multiple sclerosis drug
113986
The Food and Drug Administration strongly endorsed Biogen Idec Inc.&#39;s new multiple sclerosis treatment, putting the Cambridge firm in position to expand the market for MS drugs and win greater market share.
612544
Eli Lilly and Co. said on Tuesday that US regulators have approved its new antidepressant as a treatment for pain associated with nerve damage in diabetics
327757
LONDON - Drugs given to patients with multiple sclerosis can reduce brain tissue loss and slow down the progression of the illness, scientists said on Friday.
261321
ELEANOR HALL: It&#39;s been found to help ameliorate some of the side-effects of chemotherapy, reduce spasms associated with multiple sclerosis and help patients with chronic pain.
320147
Cancer drug shows exceptional promise as it moves toward FDA review.
135618
(National-NBC) Nov. 24, 2004 - The Food and Drug Administration has approved the first drug that specifically targets Multiple Sclerosis.
495033
NEW YORK  - Early and ongoing treatment with interferon beta-1a can provide lasting benefits to patients with relapsing-remitting multiple sclerosis (MS), according to a report in the journal Neurology.
340456
A once-a-month drug for treating  multiple sclerosis that appears to cut relapses of the  autoimmune disorder was approved on Tuesday by the U.S. Food  and Drug Administration.
467984
The US Food and Drug Administration approved a new drug to treat patients with advanced lung cancer. It&#39;s called Alimta. Patients receive ten minute infusions of the drug every three weeks on an outpatient basis.
132487
For those that missed it last night, Biogen Idec (BIIB:Nasdaq - news - research) and Elan Pharmaceuticals (ELN:NYSE ADR - news - research) received FDA approval for their new multiple sclerosis drug, now called Tysabri (formerly known as Antegren.
757229
Genzyme Corp. of Cambridge and German partner Bayer Schering Pharma AG said they have begun phase 3 trials of their cancer drug Campath to treat multiple sclerosis. The companies said they plan on reporting phase 2 results Oct. 14. After phase 3, they hope to seek US regulatory approval in 2011 to market the drug, also known as alemtuzumab, to ...
446718
The US Food and Drug Administration has approved Eli Lilly&#39;s Cymbalta, a balanced and potent serotonin and norepinephrine reuptake inhibitor.
77190
Donepezil, a drug used to treat Alzheimer's disease, seems to improve the memory of people with multiple sclerosis (MS), according to a report in the journal Neurology.
271543
The Food and Drug Administration strongly endorsed Biogen Idec Inc.'s new multiple sclerosis treatment, putting the Cambridge firm in position to expand the market for MS drugs and win greater market share. The drug, formerly called Antegren but renamed Tysabri, was developed with Elan Pharmaceuticals of Ireland. The FDA approved Tysabri for use on its own and in ...
494398
The US Food and Drug Administration on Friday approved a new Purdue Pharma LP opioid-based drug that aims to provide &quot;around-the-clock&quot; relief to patients with moderate to severe pain.
511329
Canadian regulators have given initial approval to a cannabis-based drug to treat patients suffering from multiple sclerosis, Reuters reported Dec. 21.
249246
Genentech and Biogen Idec's drug shows positive results against multiple sclerosis.